Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Tracon Pharmaceuticals Inc (TCON)

Tracon Pharmaceuticals Inc (TCON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Tracon: Q2 Earnings Snapshot

Tracon: Q2 Earnings Snapshot

TCON : 0.0322 (-25.98%)
Tracon: Q1 Earnings Snapshot

Tracon: Q1 Earnings Snapshot

TCON : 0.0322 (-25.98%)
Tracon: Q4 Earnings Snapshot

Tracon: Q4 Earnings Snapshot

TCON : 0.0322 (-25.98%)
Tracon: Q3 Earnings Snapshot

Tracon: Q3 Earnings Snapshot

TCON : 0.0322 (-25.98%)
Tracon: Q2 Earnings Snapshot

Tracon: Q2 Earnings Snapshot

TCON : 0.0322 (-25.98%)
Tracon: Q1 Earnings Snapshot

Tracon: Q1 Earnings Snapshot

TCON : 0.0322 (-25.98%)
Tracon: Q4 Earnings Snapshot

Tracon: Q4 Earnings Snapshot

TCON : 0.0322 (-25.98%)
Tracon: Q3 Earnings Snapshot

Tracon: Q3 Earnings Snapshot

TCON : 0.0322 (-25.98%)
US FDA Approval of IND for CTLA-4 Antibody YH001 for the Treatment of Front-line Sarcoma Patients in Combination with Envafolimab

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen") and TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), today jointly announced that the U.S. Food and Drug Administration (FDA) has approved the...

TCON : 0.0322 (-25.98%)
TRACON Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

SAN DIEGO, Aug. 10, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a...

TCON : 0.0322 (-25.98%)

Barchart Exclusives

Profit from Natural Resources with This 1 Stock Up 80%
Glencore (GLNCY) has gained nearly 80% over the past 52 weeks. Shares maintain a Trend Seeker “Buy” signal and a 100% “Buy” opinion from Barchart. Fundamentals are attractive with 56% estimated earnings growth this year. Strong sentiment and analyst ratings support GLNCY here. Today’s Featured Stock Valued at $80.56 billion,... Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.